Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1979 1
1982 1
1983 1
1984 3
1988 2
1991 1
1993 3
1994 2
1995 2
1996 4
1997 3
1998 5
1999 4
2000 2
2001 8
2002 7
2003 2
2004 5
2005 9
2006 6
2007 5
2008 7
2009 5
2010 7
2011 9
2012 18
2013 13
2014 21
2015 24
2016 31
2017 26
2018 28
2019 31
2020 26
2021 24
2022 16
Text availability
Article attribute
Article type
Publication date

Search Results

323 results
Results by year
Filters applied: . Clear all
Page 1
Diabetic neuropathy.
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V. Feldman EL, et al. Among authors: bril v. Nat Rev Dis Primers. 2019 Jun 13;5(1):41. doi: 10.1038/s41572-019-0092-1. Nat Rev Dis Primers. 2019. PMID: 31197153 Review.
Diabetic neuropathy.
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V. Feldman EL, et al. Among authors: bril v. Nat Rev Dis Primers. 2019 Jun 13;5(1):42. doi: 10.1038/s41572-019-0097-9. Nat Rev Dis Primers. 2019. PMID: 31197183 Free PMC article.
Treatment Approaches for Atypical CIDP.
Menon D, Katzberg HD, Bril V. Menon D, et al. Among authors: bril v. Front Neurol. 2021 Mar 15;12:653734. doi: 10.3389/fneur.2021.653734. eCollection 2021. Front Neurol. 2021. PMID: 33790853 Free PMC article. Review.
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, Murai H, Bilinska M, Shakarishvili R, Smilowski M, Guglietta A, Ulrichts P, Vangeneugden T, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT Investigator Study Group. Howard JF Jr, et al. Among authors: bril v. Lancet Neurol. 2021 Jul;20(7):526-536. doi: 10.1016/S1474-4422(21)00159-9. Lancet Neurol. 2021. PMID: 34146511 Clinical Trial.
Novel Treatments in Myasthenia Gravis.
Menon D, Barnett C, Bril V. Menon D, et al. Among authors: bril v. Front Neurol. 2020 Jun 30;11:538. doi: 10.3389/fneur.2020.00538. eCollection 2020. Front Neurol. 2020. PMID: 32714266 Free PMC article. Review.
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.
Howard JF Jr, Bril V, Burns TM, Mantegazza R, Bilinska M, Szczudlik A, Beydoun S, Garrido FJRR, Piehl F, Rottoli M, Van Damme P, Vu T, Evoli A, Freimer M, Mozaffar T, Ward ES, Dreier T, Ulrichts P, Verschueren K, Guglietta A, de Haard H, Leupin N, Verschuuren JJGM; Efgartigimod MG Study Group. Howard JF Jr, et al. Among authors: bril v. Neurology. 2019 Jun 4;92(23):e2661-e2673. doi: 10.1212/WNL.0000000000007600. Epub 2019 May 22. Neurology. 2019. PMID: 31118245 Free PMC article. Clinical Trial.
Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.
Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, Zochodne D; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Bril V, et al. Neurology. 2011 May 17;76(20):1758-65. doi: 10.1212/WNL.0b013e3182166ebe. Epub 2011 Apr 11. Neurology. 2011. PMID: 21482920 Free PMC article. Review.
Diabetic neuropathies: a statement by the American Diabetes Association.
Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D; American Diabetes Association. Boulton AJ, et al. Among authors: bril v. Diabetes Care. 2005 Apr;28(4):956-62. doi: 10.2337/diacare.28.4.956. Diabetes Care. 2005. PMID: 15793206 Review. No abstract available.
323 results